Genomic
Health, Inc
|
||||
(Name
of Issuer)
|
||||
Common
Stock, par value $0.0001 per share
|
||||
(Title
of Class of Securities)
|
||||
37244C101
|
||||
(CUSIP
Number)
|
||||
Leo
Kirby
667
Madison Avenue, 17th Floor
New
York, NY 10021
(212)
339-5633
|
||||
(Name,
Address and Telephone Number of Person Authorized to Receive Notices
and
Communications)
|
||||
May
21, 2007
|
||||
(Date
of Event which Requires Filing of this Statement)
|
||||
CUSIP
No. 37244C101
|
Page 2 of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Julian
C. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a)
o
(b) x
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d)
OR 2(e)
|
||||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
0
|
|||
8
|
SHARED
VOTING POWER
4,975,237
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
4,975,237
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,975,237
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
x
|
|||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
18.0%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP
No. 37244C101
|
Page 3 of
8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Felix
J. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a) o
(b) x
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d)
OR 2(e)
|
||||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
4,966,987
|
|||
8
|
SHARED
VOTING POWER
4,966,987
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
4,966,987
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,966,987
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
x
|
|||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
18.0%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Name
|
Business
Address
|
Present
Principal Occupation
|
Julian
C. Baker
|
667
Madison Avenue
New
York, NY 10021
|
Managing
Member, Baker Bros. Advisors, LLC (an entity engaged in investment
activities)
|
Felix
J. Baker
|
667
Madison Avenue
New
York, NY 10021
|
Managing
Member, Baker Bros. Advisors, LLC (an entity engaged in investment
activities)
|
Percent
of class
|
|||||||
Name
|
Number
of Shares
|
Outstanding
|
|||||
Baker
Bros. Investments, L.P.
|
173,897
|
0.6
|
%
|
||||
Baker
Bros. Investments II, L.P.
|
20,095
|
0.1
|
%
|
||||
Baker
Biotech Fund I, L.P.
|
1,150,104
|
4.2
|
%
|
||||
Baker
Brothers Life Sciences, L.P.
|
3,171,209
|
11.5
|
%
|
||||
14159,
L.P.
|
84,026
|
0.3
|
%
|
||||
Baker/Tisch
Investments, L.P.
|
193,759
|
0.7
|
%
|
||||
FBB
Associates
|
173,897
|
0.6
|
%
|
||||
Julian
C. Baker
|
8,250
|
0.0
|
%
|
||||
Total
|
4,975,237
|
18.0
|
%
|
Baker
Bros. Investments II, L.P.
|
5/23/2007
|
177
|
Purchase
|
16.4015
|
Baker
Biotech Fund I, L.P.
|
5/23/2007
|
26,373
|
Purchase
|
16.4015
|
Baker
Brothers Life Sciences, L.P.
|
5/23/2007
|
69,553
|
Purchase
|
16.4015
|
14159,
L.P.
|
5/24/2007
|
375
|
Purchase
|
16.3107
|
Baker
Bros. Investments II, L.P.
|
5/24/2007
|
30
|
Purchase
|
16.3107
|
Baker
Biotech Fund I, L.P.
|
5/24/2007
|
4,480
|
Purchase
|
16.3107
|
Baker
Brothers Life Sciences, L.P.
|
5/24/2007
|
11,815
|
Purchase
|
16.3107
|
14159,
L.P.
|
5/24/2007
|
1,691
|
Purchase
|
16.3525
|
Baker
Bros. Investments II, L.P.
|
5/24/2007
|
136
|
Purchase
|
16.3525
|
Baker
Biotech Fund I, L.P.
|
5/24/2007
|
20,175
|
Purchase
|
16.3525
|
Baker
Brothers Life Sciences, L.P.
|
5/24/2007
|
53,210
|
Purchase
|
16.3525
|
14159,
L.P.
|
5/25/2007
|
3,514
|
Purchase
|
16.2443
|
Baker
Bros. Investments II, L.P.
|
5/25/2007
|
282
|
Purchase
|
16.2443
|
Baker
Biotech Fund I, L.P.
|
5/25/2007
|
41,909
|
Purchase
|
16.2443
|
Baker
Brothers Life Sciences, L.P.
|
5/25/2007
|
110,529
|
Purchase
|
16.2443
|
14159,
L.P.
|
5/29/2007
|
2,875
|
Purchase
|
16.3862
|
Baker
Bros. Investments II, L.P.
|
5/29/2007
|
230
|
Purchase
|
16.3862
|
Baker
Biotech Fund I, L.P.
|
5/29/2007
|
34,288
|
Purchase
|
16.3862
|
Baker
Brothers Life Sciences, L.P.
|
5/29/2007
|
90,428
|
Purchase
|
16.3862
|
14159,
L.P.
|
5/30/2007
|
339
|
Purchase
|
16.4383
|
Baker
Bros. Investments II, L.P.
|
5/30/2007
|
27
|
Purchase
|
16.4383
|
Baker
Biotech Fund I, L.P.
|
5/30/2007
|
2,247
|
Purchase
|
16.4383
|
Baker
Brothers Life Sciences, L.P.
|
5/30/2007
|
10,683
|
Purchase
|
16.4383
|
14159,
L.P.
|
5/30/2007
|
79
|
Purchase
|
16.4646
|
Baker
Bros. Investments II, L.P.
|
5/30/2007
|
6
|
Purchase
|
16.4646
|
Baker
Biotech Fund I, L.P.
|
5/30/2007
|
518
|
Purchase
|
16.4646
|
Baker
Brothers Life Sciences, L.P.
|
5/30/2007
|
2,459
|
Purchase
|
16.4646
|
May 30, 2007 | ||
|
|
|
By: | /s/ Julian C. Baker | |
Julian C. Baker |
||
|
|
|
By: | /s/ Felix J. Baker | |
Felix J. Baker |
||
May 30, 2007 | ||
|
|
|
By: | /s/ Julian C. Baker | |
Julian C. Baker |
||
|
|
|
By: | /s/ Felix J. Baker | |
Felix J. Baker |
||